Warburg sells pharmaceutical company to KKR

The exit of ReSearch Pharmaceutical Services marks the second time Warburg has sold a portfolio company to KKR this year, following the sale of tire maker Alliance Tire Group in April.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this